EUVIMEDEUVIMED entdecken
Crossref

Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins

Amalia Christina Vadmand iD, Anne Anker Nissen, Sidsel Mathiesen, Maria Ebbesen Soerum iD, Tina Gerbek, Martin Kaj Fridh, Kaspar Sørensen, Bolette Hartmann iD, Jens Juul Holst iD, Klaus Müller iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgac561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Amalia Christina Vadmand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, DK-2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Metabolic Syndrome, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: The Danish Cancer Society, The Medical Sciences Part of the Faculty of Health and Medical Sciences’ Foundation, University of Copenhagen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Survivors of pediatric hematopoietic stem cell transplantation (HSCT) have increased risk of developing metabolic syndrome (MetS), but the mechanisms are poorly understood.

Objective

We aimed to test the hypothesis that insufficient secretion of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) plays a pathogenetic role in HSCT survivors with MetS.

Methods

This cross-sectional cohort study, conducted at the Danish national referral center for HSCT, studied 42 male HSCT survivors (median age 28.9 years) for a median 21.2 years from HSCT, along with 15 age- and sex-matched healthy controls. Main outcome measures were glucose metabolism and incretin hormones (by oral glucose tolerance test [OGTT]) and MetS criteria. The hypothesis was formulated before data collection.

Results

GLP-1, GIP, and glucagon during an OGTT were similar in patients and controls, with no overall difference between survivors with (24%) and without MetS. However, fasting glucagon was significantly higher in patients with hypertriglyceridemia (mean difference [MD]: 6.1 pmol/L; 95% CI, 1.5-10.8; P = 0.01), and correlated with HDL (MD: 4.7 mmol/L; 95% CI, −0.6 to 9.9; P = 0.08), android-gynoid ratio (correlation coefficient [r] = 0.6, P = 0.0001) and waist-hip ratio (r = 0.5, P = 0.002). A similar pattern was seen for GIP, correlating positively with triglyceride (MD: 60%; 95% CI, 44-82; P = 0.002). GIP levels were significantly increased in patients treated with total body irradiation (TBI) (MD: 165%; 95% CI, 118-230; P = 0.004), which was found to be a significant risk factor for MetS.

Conclusion

This study demonstrates an altered production of incretin hormones in HSCT survivors previously treated with TBI, developing dyslipidemia and abdominal adiposity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeHematopoietic Stem Cell TransplantationHumansMaleAdultChildIncretinsGlucagonCross-Sectional StudiesBlood GlucoseGlucagon-Like Peptide 1Gastric Inhibitory PolypeptideSurvivorsInsulin

Stichwörter der Autor:innen

glucagon-like peptide-1glucose-dependent insulinotropic polypeptidehematopoietic stem cell transplantationlate effectsmetabolic syndromepediatric

Substanzen

IncretinsGlucagonBlood GlucoseGlucagon-Like Peptide 1Gastric Inhibitory PolypeptideInsulin

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, DK-2100 Copenhagen, Denmark.
  • The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, DK-2200 Copenhagen N, Denmark.
  • Department of Biomedical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark.
  • Institute for Inflammation Research, University Hospital Rigshospitalet, DK-2100 Copenhagen, Denmark.

ORCID-Profile: Amalia Christina Vadmand, Maria Ebbesen Soerum, Bolette Hartmann, Jens Juul Holst, Klaus Müller

Förderung

  • The Danish Cancer Society
  • The Medical Sciences Part of the Faculty of Health and Medical Sciences’ Foundation
  • University of Copenhagen

Zitieren

APA

Vadmand, A. C., Nissen, A. A., Mathiesen, S., Soerum, M. E., Gerbek, T., Fridh, M. K., Sørensen, K., Hartmann, B., Holst, J. J., & Müller, K. (2023). Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac561

Vancouver

Vadmand AC, Nissen AA, Mathiesen S, Soerum ME, Gerbek T, Fridh MK, et al. Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgac561

BibTeX
@article{Vadmand2023,
  author = {Vadmand, Amalia Christina and Nissen, Anne Anker and Mathiesen, Sidsel and Soerum, Maria Ebbesen and Gerbek, Tina and Fridh, Martin Kaj and Sørensen, Kaspar and Hartmann, Bolette and Holst, Jens Juul and Müller, Klaus},
  title = {Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgac561}
}
Kostenlos starten →